Form 8-K - Current report:
SEC Accession No. 0001437749-24-027952
Filing Date
2024-08-28
Accepted
2024-08-28 17:12:58
Documents
14
Period of Report
2024-08-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20240827_8k.htm   iXBRL 8-K 20912
  Complete submission text file 0001437749-24-027952.txt   151652

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240828.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240828_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240828_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240828_pre.xml EX-101.PRE 11584
16 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240827_8k_htm.xml XML 2812
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 241256625
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)